What dose of bumetanide (Bumex) is equivalent to 80 mg of furosemide (Lasix)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bumetanide Equivalent to 80 mg Furosemide

2 mg of bumetanide (Bumex) is equivalent to 80 mg of furosemide (Lasix). 1, 2

Established Equivalence Ratio

  • The standard conversion ratio is 1:40, meaning 1 mg of bumetanide equals 40 mg of furosemide. 1, 2
  • Therefore, 80 mg of furosemide requires 2 mg of bumetanide (80 ÷ 40 = 2). 1
  • This 1:40 potency ratio is consistently supported across FDA labeling, clinical guidelines, and pharmacological research. 1, 2, 3

Route-Specific Considerations

  • For IV administration: 2 mg bumetanide IV equals 80 mg furosemide IV using the same 1:40 ratio. 1, 2
  • For oral administration: The conversion remains 2 mg bumetanide PO equals 80 mg furosemide PO, though bumetanide has superior bioavailability (80% vs 40% for furosemide). 4, 5
  • When converting from IV to oral routes, bumetanide's higher bioavailability means the oral dose can remain the same as the IV dose, whereas furosemide often requires dose increases. 4

Critical Pharmacokinetic Differences

  • Duration of action: Bumetanide has a significantly shorter duration (4-6 hours) compared to furosemide (6-8 hours), often necessitating twice-daily dosing rather than once-daily. 1
  • Onset of action: Both drugs produce diuresis within minutes IV and peak at 30-75 minutes orally, with virtually superimposable time-response curves. 6, 4
  • Bioavailability advantage: Bumetanide's 80% oral bioavailability versus furosemide's 40% makes oral bumetanide more reliable, particularly in heart failure patients with gut edema. 4, 5

Practical Dosing Algorithm for Conversion

Step 1: Calculate equivalent dose using 1:40 ratio

  • 80 mg furosemide ÷ 40 = 2 mg bumetanide 1, 2

Step 2: Adjust dosing frequency

  • If patient was on furosemide 80 mg once daily, consider bumetanide 1 mg twice daily (morning and early afternoon) due to shorter duration. 1
  • Alternatively, start with 2 mg once daily and monitor response over 24 hours. 1

Step 3: Monitor response within 24-48 hours

  • Check daily weights targeting 0.5-1.0 kg loss per day. 1
  • Assess urine output and clinical signs of congestion. 1
  • Verify electrolytes (sodium, potassium) and renal function within 1-2 weeks. 1

Important Clinical Caveats

  • Maximum daily dose: Bumetanide should not exceed 10 mg/day. 1
  • Electrolyte monitoring: For every 200 mEq sodium excreted, bumetanide causes approximately 35 mEq potassium loss versus 50 mEq with furosemide, though this difference is not clinically significant. 6
  • Diuretic resistance: If adequate diuresis is not achieved with bumetanide 2 mg twice daily (equivalent to furosemide 160 mg/day), add a thiazide diuretic or aldosterone antagonist rather than exceeding maximum loop diuretic doses. 1
  • Heart failure patients: Delayed absorption in CHF reduces peak drug concentrations for both agents, potentially requiring higher doses or IV administration. 5
  • Ototoxicity risk: Bumetanide may have a lower incidence of ototoxicity compared to furosemide, making it preferable in high-risk patients. 3, 7

Common Pitfalls to Avoid

  • Underdosing due to short duration: Do not assume once-daily bumetanide 2 mg will provide 24-hour coverage equivalent to furosemide 80 mg once daily; consider split dosing. 1
  • Ignoring bioavailability advantage: In patients with gut edema or malabsorption, bumetanide's superior oral bioavailability makes it more reliable than furosemide. 4, 5
  • Combining with NSAIDs: Avoid concurrent NSAID use, which blocks diuretic effects and worsens renal function. 1
  • Excessive sodium intake: High dietary sodium (>2-3 g/day) can create apparent diuretic resistance; counsel patients on sodium restriction. 1

References

Guideline

Converting from Bumetanide to Torsemide

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Bumetanide and furosemide.

Clinical pharmacology and therapeutics, 1983

Research

Bumetanide and furosemide in heart failure.

Kidney international, 1984

Research

Bumetanide: a new loop diuretic (Bumex, Roche Laboratories).

Drug intelligence & clinical pharmacy, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.